Board of Trustees
Martin J. Abrahamson, M.D., Senior Vice President and Joslin Clinic Medical Director, Joslin Diabetes Center, Boston, MA
T. Keith Blackwell, M.D., Ph.D., Senior Investigator and Head of the Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, Boston, MA
John L. Brooks, III, Vice Chairman of the Board, General Partner, Prism Venture Partners, Westwood, MA
C. Richard Carlson, Senior Vice President, UBS Financial Service, Inc., Boston, MA
Don R. Conlan, South Pasadena, CA
Kevin E. Conley, Chairman of the Board, Joslin Diabetes Center; President and CEO, Conley & Company, Boston, MA
John J. Cook, Jr., Managing Director, Seaward Management Corp., Wellesley, MA
Nathaniel S. Gardiner, Edwards Angell Palmer & Dodge, Boston, MA
Phillip Gorden, M.D., NIDDK Director Emeritus, National Institutes of Health, Bethesda, MD
Morella M. Grossmann, Caracas, Venezuela
Dennis C. Guittarr, Duxbury, MA
Charles H. Hood, Brookline, MA
Ralph M. James, Executive Director, Executive Education, Harvard Business School, Boston, MA
C. Ronald Kahn, M.D., Senior Investigator and Head of the Section on Obesity and Hormone Action, the Mary K. Iacocca Professor of Medicine at Harvard Medical School, and Vice Chairman of the Joslin Board, Joslin Diabetes Center, Boston, MA
Ranch C. Kimball, President and CEO, Joslin Diabetes Center, Boston, MA
Steven N. Kane, Brookline, MA
George L. King, M.D., Senior Vice President and Research Director, Joslin Diabetes Center, Boston, MA
Ann M. Lagasse, Piper Properties Management, Newburyport, MA
Gary W. Loveman, Chairman, President and CEO, Harrah's Entertainment Inc., Las Vegas, NV
Diane J. Mathis, Ph.D., Co-Head, Section on Immunology and Immunogenetics, Joslin Diabetes Center, Boston, MA
Peter H. Mattoon, CEO, SCS Financial, LLC, Waltham, MA
W. Alan McCollough, Richmond, VA
Frances H. Miller, Professor of Law, Boston University School of Law, Boston, MA
Robert E. Patterson, Chairman Emeritus, Joslin Diabetes Center; Chairman, Cabot Properties, Boston, MA.
James L. Peterson, JLP Group, Geneva, Switzerland
Geoffrey S. Rehnert, Founder and Co-CEO, Audax Management Co. LLC, Boston, Mass.
Richard A. Smith, Chestnut Hill, MA
Robert C. Stanton, M.D., Chief of Nephrology, Joslin Diabetes Center, Boston, MA
Christopher T. Stix, Weston, MA
Jess E. Sweely, Madison, VA
J. Christine Wilson, Pittsford, NY; Vice Chairman of the Board, Joslin Diabetes Center, Boston, MA
William T. Young, Jr., President, W.T. Young, Inc., Lexington, KY
Honorary Trustees:
George F. Cahill, Jr., M.D., Stoddard, NH
Herbert G. Graetz, West Newton, MA
Patrick H. O’Neill, New Canaan, CT
Kenneth E. Quickel, M.D., Centerville, MA
Overseers
Jerome Ade, New York, NY
John Adler, Greenwich, CT
Barry Altschul, Framingham, MA
Brenda Altschul, Framingham, MA
Joseph A. Arendt, Boxborough, MA
Ronald A. Arky, M.D., Harvard Medical School, Boston, MA
Robert Ashenbrenner, Austin, TX
Edgar Astrove, Scarsdale, NY
Donald M. Barnett, M.D., Brookline, MA
Harry C. Barr, Boston, MA
Thomas J. Beatson, Phoenix, AZ
Laurie J. Bejoian, Watertown, MA
Frederick N. Biesecker, Boyertown, PA
T. Keith Blackwell, M.D., Ph.D.
Nick Boynton, Boston, MA
Emily Branka, Medfield, MA
Gerard Branka, Medfield, MA
Ann Bray, Warwick, RI
Jeffrey Brewer, New York, NY
F. Gorham Brigham, Jr., West Newton, MA
Sally Cahill, Stoddard, NH
Scott Campbell, Chevy Chase, MD
Vicki Campbell, Chevy Chase, MD
Arnold Chase, Hartford, CT
Arthur Choate, Coral Gables, FL
A. Richard Christlieb, M.D., Ft. Meyers Beach, FL
Constance B. Coburn, Boston, MA
Dayton Coles, State College, PA
Regina Niner Conley, Weston, MA
Joette Cook, Wellesley Hills, MA
Tammy Crawford, Gilbert, AZ
W. Michael Crawford, Rowayton, CT
Thomas DiBenedetto, Boston, MA
Deborah Digges, Towson, MD
Jane N. Dixon, Cambridge, MA
Sean Doherty, Boston, MA
Robert P. Donahoe, Canton, MA
Charles Downer, Boston, MA
Lee Ducat, Chicago, IL
Gerald F. Dunfey, Portsmouth, NH
Howard M. Ellis, Fairfield, NJ
Barbara Elliott Fargo, Grafton, MA
Bronson H. Fargo Jr., Norfolk, England
Pamala M. Fernandes, Needham, MA
Jay L. Fialkow, Newton, MA
G. Franklin Fish, Foxboro, MA
John D. Freeman, Boston, MA
Dr. James Gavin, III, Atlanta, GA
Robert C. Ginsberg, Boca Raton, FL
Carole Bosman Goldberg, Waltham, MA
Carla Gomes, Boston, MA
Ilene Greenberg, Chestnut Hill, MA
W. Michael Gretschel, Chevy Chase, MD
Maureen Gretschel, Chevy Chase, MD
Glenn Gutwillig, Concord, MA
Andrew C. Halvorsen, Summit, NJ
Kevin M. Harrington, Canton, MA
Stephen M. Hendricken, Hull, MA
Candace L. Heublein, Canton, CT
Jay Hewitt, Greenville, SC
Joseph E. Hill, Boston, MA
Larry Ho, Beverly Hills, CA
Sally Ho, Beverly Hills, CA
Edward S. Horton, M.D., Director of Clinical Research, Joslin Diabetes Center
Carol L. Horvitz, Beverly Farms, MA
James D. Houghton, Boston, MA
Lee A. Iacocca, Los Angeles, CA
Roderick Ireland, Boston, MA
Cheryl A. Jacques, Washington, D.C.
Nicole Johnson, Tampa, FL
Steven Kane, Boston, MA
Hiroo Kaneda, Japan
Khaled Kanoo, Manama, Bahrain
Lila W. Kirkland, Palm Beach, FL
Edward R. Koller, Jr., New York, NY
Steven P. Koppel, Reading, MA
Debra Krasnow, Needham, MA
James Krasnow, Needham, MA
Raymond Kurzweil, Wellesley, MA
Chuck Lagasse, Newburyport, MA
Christine Laine, M.D., Wynnewood, PA
John C. Lechleiter, Ph.D., Indianapolis, IN
Victor J. Leone, Jr., Lynnfield, MA
Shaun Levesque, Wrentham, MA
Kathleen Levesque, Wrentham, MA
Paul F. Levy, President and CEO, Beth Israel Deaconess Medical Center, Boston, MA
Paul C. Lowerre, New York, NY
Caroline S. Lurie, New York, NY
Thomas C. Lynch, Shirley, MA
Boyd Lyon, Sr., Union, SC
Richard R. MacDonald, Saugus, MA
Paul B. Madden, Boston, MA
Jerome Magner, Providence, RI
James M. Martell, Arlington, VA
Jessie McCollough, Richmond, VA
Harry Brown McCormick, Boston, MA
Sharon A. McCormick, Boston, MA
F. Sutton McGehee, Jr., Jacksonville, FL
Douglas E. McQuade, Riverhead, NY
Douglas A. Melton, Ph.D., Harvard University, Cambridge, MA
Carol Meyrowitz, Newton, MA
Stanley Mirsky, M.D., New York, NY
Rita Moskin, New York, NY
James Mulvihill, Kennebunkport, ME
John R. O’Laughlin II, Newton, MA
Daniel Omstead, Boston, MA
Patrick H. O’Neill, New Canaan, CT
William M. Parent, Boston, MA
Louise Penta, Boston, MA
Diane Phelan, Wayland, MA
Thomas L. Phillips, Lexington, MA
Ridgway Powell, Boston, MA
William M. Quackenbush, Amarillo, TX
Kenneth E. Quickel, Jr., M.D., Past President and CEO, Joslin Diabetes Center; Centerville, MA
Lawrence I. Rand, M.D., Waban, MA
John Ratzenberger, Calabasas, CA
A. Roy Rosenthal, M.D., P.A., Potomac, MD
Ellen S. Rosenthal, Potomac, MD
Nina M. Roth, Jacksonville, FL
Celia D. Rumsey, Santa Fe, NM
Vincent A. Sarni, Pittsburgh, PA
Thomas M. Scott, Shawnee Mission, KS
Bruce P. Shaw, Boston, MA
Martin Soeters, Princeton, NJ
Robert G. Spiro, M.D., Senior Investigator Emeritus, Joslin Diabetes Center, Boston, MA
Howard Steinberg, Westport, CT
Christopher Stix, Weston, MA
Robert E. Taylor, Rockville Center, NY
Mary Jane Tiedeman, Bethesda, MD
Jane S. Thompson, Miami Beach, FL
Lyle Thompson, Miami Beach, FL
Christopher H. Volk , Scottsdale, AZ
Hollis Hutchens Volk, Paradise Valley, AZ
Laura Kee Wade, Palermo, ME
Bruce D. Wedlock, Sc.D., North Reading, MA
David Weinberg, M.D., Wynnewood, PA
Gordon C. Weir, M.D., Diabetes Research and Wellness Foundation Chair at Joslin Diabetes Center, Boston, MA
Jasper White, Lincoln, MA
C. Lynn Wickwire, Concord, MA
David S. Wilson, Needham, MA
Joyce M. Wilson, Needham, MA
Leverett Wing, Boston, MA
David Winstead, Chevy Chase, MD
Page Winstead, Chevy Chase, MD
Dennis Wolfson, Jacksonville, FL
Eugene Wong, Danville, CA
Lai Wong, Danville, CA
M. Donna Younger, M.D., Joslin Diabetes Center, Boston, MA
Andrea Ziegler, Bernardsville, NJ
Francis Ziegler, Bernardsville, NJ
HONORARY MEMBERS
Lloyd M. Aiello, M.D., Founding Director, William P. Beetham Eye Institute, Joslin Diabetes Center
Frank A. Augsbury, Jr. Ogdensburg, NY
Joslin President and CEO
 Ranch C. Kimball is President and Chief Executive Officer of Joslin Diabetes Center, the world’s largest diabetes research center, diabetes clinic, and provider of diabetes education. As Joslin’s seventh president and first business executive to hold these roles, Kimball sets the strategic direction of the organization and oversees all operations regarding its growth, and is focused on expanding the impact of Joslin on the healthcare epidemic of our time.
Kimball joined Joslin in February 2007 after serving as the Secretary of Economic Development for the Commonwealth of Massachusetts. As Governor Mitt Romney’s Chief Economic Advisor, he oversaw 22 agencies, four cabinet secretaries and more than 2,500 employees ranging from those at the Departments of Labor, Workforce Development, and Business & Technology, to the Office of Consumer Affairs & Business Regulation.
Kimball has a demonstrated ability to build strong connections between state government, business and academic organizations for the purpose of finding new and innovative support for biomedical research. Susan Hockfield, President of M.I.T., hailed Kimball’s appointment and said, “Given his strong record of commitment to research and innovation, I know that he will work to ensure Joslin’s continued preeminence as a resource for our region, the nation and the world.”
Widely known and respected in the business community, Kimball led major reforms in improving Massachusetts’ economic development and achieved a long record of legislative success. Community leaders in Boston support his new role, with Boston Mayor Thomas Menino calling Kimball “one of the city's most respected and well-known business leaders, and a real star in the Romney administration."
In 2004, Kimball created the “Business Resource Team,” the state’s one-stop model for businesses seeking to grow in Massachusetts. In June 2006, the BRT celebrated its 219th and most significant victory, bringing Bristol Myers Squibb’s billion dollar bio-manufacturing plant to Fort Devens. Kimball also helped write the Governor’s Economic Stimulus Bill, took a role in promoting the Governor’s healthcare reform package and toured more than 250 companies. Jack Connors, Chairman of Hill Holliday and Chairman of Partners Healthcare, remarked “Kimball is an outstanding choice for Joslin.” Connors noted, “With Kimball’s expertise in leadership, life sciences and his demonstrated ability to build relationships between legislative, business and academic communities, the Joslin will thrive and prosper.”
In 2006, Kimball received the Biotech Industry Organization’s award for top state executive in the nation. The Massachusetts Network Communications Council named Kimball one of its “Policy Makers of the Year” for 2005.
Kimball is Chair of Mass Development, the state’s finance authority that controls $650 million in land for redevelopment and issues $2 billion a year in bonds, and he sits on the Massport board. Active in the community, he also serves on the boards of the Museum of Fine Arts, WGBH-TV, the Museum of Science and Wheelock College.
Previously, Kimball spent 25 years in the private sector helping businesses grow. He ran a private equity firm for Kissinger McLarty Associates and was a partner at Boston Consulting Group, working extensively with technology, telecommunications, manufacturing, media and healthcare companies during his 16-year tenure.
Kimball received an A.B. in Economics from Princeton University in 1980 and lives in Brookline, Mass., with his wife and two sons.
Officers of the Corporation
Elected Officers
Kevin E. Conley, Chairman of the Board
John L. Brooks, III, First Vice Chair
J. Christine Wilson, Vice Chair
C. Ronald Kahn, M.D., Vice Chair
Ranch C. Kimball, President and CEO
Dianne McCarthy, Clerk
Executive Staff
Martin J. Abrahamson, M.D., Senior Vice President, Medical Director
George L. King, M.D., Senior Vice President, Research Director
Michael Sullivan, Vice President, Development
Paul A. O'Brien, Senior Vice President, Joslin Ventures
Dianne McCarthy, General Counsel
Debra Canner, Vice President, Human Resources
Rachel J. Whitehouse, Vice President, Communications and Public Relations
|
